Allergan Aesthetics' Boey Receives European Commission Approval To Treat Moderate To Severe Lines Between The Eyebrows
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the European Commission has approved Boey® (trenibotulinumtoxinE) in Europe, for the temporary improvement in the appearance of moderate to severe lines
Allergan got permission from Europe to sell a new wrinkle-smoothing medicine called Boey. This is good news because it means the company can now make and sell this product in Europe, which could help bring in more money.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.